Cargando…

Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up

BACKGROUND AND PURPOSE: Transient tumor swelling is a well-known phenomenon following radiotherapy for vestibular schwannomas (VS). We analyzed the long-term volumetric changes of VS after LINAC radiosurgery, in order to determine a time interval during which a true tumor progression can be distingu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouard, O., Daisne, J.F., Wanet, M., Regnier, M., Gustin, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688865/
https://www.ncbi.nlm.nih.gov/pubmed/34977365
http://dx.doi.org/10.1016/j.ctro.2021.12.003
_version_ 1784618437476089856
author Fouard, O.
Daisne, J.F.
Wanet, M.
Regnier, M.
Gustin, T.
author_facet Fouard, O.
Daisne, J.F.
Wanet, M.
Regnier, M.
Gustin, T.
author_sort Fouard, O.
collection PubMed
description BACKGROUND AND PURPOSE: Transient tumor swelling is a well-known phenomenon following radiotherapy for vestibular schwannomas (VS). We analyzed the long-term volumetric changes of VS after LINAC radiosurgery, in order to determine a time interval during which a true tumor progression can be distinguished from a pseudoprogression. METHODS: Among 63 patients with VS treated by one fraction or fractionated radiotherapy, we selected 52 of them who had a minimal follow-up of 5 years. Maximal axial diameter and three-dimensional tumor volume were measured on each MRI scan. Volume changes were interpreted using different error margins ranging from 10 to 20%. Patients were categorized according to the tumor evolution pattern over time. RESULTS: Median follow-up was 83 months. One tumor (1.9%) remained stable and 26.9% had continuous shrinkage. Applying an error margin of 13%, a transient tumor enlargement was observed in 63.5% of patients, with a first peak at 6–12 months and a late peak at 3–4 years. A true progression was suspected in 4 (7.7%) patients, tumor regrowth starting after the 3rd or 4th year post-treatment. Only one patient required salvage radiotherapy. CONCLUSION: Transient swelling of VS following radiotherapy is generally an early phenomenon but may occur late. In the first 5 years, a true tumor progression cannot be differentiated from a pseudoprogression. A significant tumor expansion observed on 3 sequential MRI scans after the 3rd year may be suggestive of treatment failure. Long-term follow-up is therefore mandatory and no decision of salvage treatment should be made until the 6th year.
format Online
Article
Text
id pubmed-8688865
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86888652021-12-30 Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up Fouard, O. Daisne, J.F. Wanet, M. Regnier, M. Gustin, T. Clin Transl Radiat Oncol Article BACKGROUND AND PURPOSE: Transient tumor swelling is a well-known phenomenon following radiotherapy for vestibular schwannomas (VS). We analyzed the long-term volumetric changes of VS after LINAC radiosurgery, in order to determine a time interval during which a true tumor progression can be distinguished from a pseudoprogression. METHODS: Among 63 patients with VS treated by one fraction or fractionated radiotherapy, we selected 52 of them who had a minimal follow-up of 5 years. Maximal axial diameter and three-dimensional tumor volume were measured on each MRI scan. Volume changes were interpreted using different error margins ranging from 10 to 20%. Patients were categorized according to the tumor evolution pattern over time. RESULTS: Median follow-up was 83 months. One tumor (1.9%) remained stable and 26.9% had continuous shrinkage. Applying an error margin of 13%, a transient tumor enlargement was observed in 63.5% of patients, with a first peak at 6–12 months and a late peak at 3–4 years. A true progression was suspected in 4 (7.7%) patients, tumor regrowth starting after the 3rd or 4th year post-treatment. Only one patient required salvage radiotherapy. CONCLUSION: Transient swelling of VS following radiotherapy is generally an early phenomenon but may occur late. In the first 5 years, a true tumor progression cannot be differentiated from a pseudoprogression. A significant tumor expansion observed on 3 sequential MRI scans after the 3rd year may be suggestive of treatment failure. Long-term follow-up is therefore mandatory and no decision of salvage treatment should be made until the 6th year. Elsevier 2021-12-09 /pmc/articles/PMC8688865/ /pubmed/34977365 http://dx.doi.org/10.1016/j.ctro.2021.12.003 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Fouard, O.
Daisne, J.F.
Wanet, M.
Regnier, M.
Gustin, T.
Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up
title Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up
title_full Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up
title_fullStr Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up
title_full_unstemmed Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up
title_short Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up
title_sort long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: practical implications for follow-up
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688865/
https://www.ncbi.nlm.nih.gov/pubmed/34977365
http://dx.doi.org/10.1016/j.ctro.2021.12.003
work_keys_str_mv AT fouardo longtermvolumetricanalysisofvestibularschwannomasfollowingstereotacticradiotherapypracticalimplicationsforfollowup
AT daisnejf longtermvolumetricanalysisofvestibularschwannomasfollowingstereotacticradiotherapypracticalimplicationsforfollowup
AT wanetm longtermvolumetricanalysisofvestibularschwannomasfollowingstereotacticradiotherapypracticalimplicationsforfollowup
AT regnierm longtermvolumetricanalysisofvestibularschwannomasfollowingstereotacticradiotherapypracticalimplicationsforfollowup
AT gustint longtermvolumetricanalysisofvestibularschwannomasfollowingstereotacticradiotherapypracticalimplicationsforfollowup